International ME/CFS Conference 2025

Agenda

12.05.2025 - Monday (Day 1)

All times are in Central European Summer Time (CEST).

Introduction

Chairs
Carmen Scheibenbogen
Carmen Scheibenbogen, Charité – Universitätsmedizin Berlin, Germany
David Putrino
David Putrino, Icahn School of Medicine at Mount Sinai, New York, USA
10:00
5 min

Welcome

Carmen Scheibenbogen
Carmen Scheibenbogen, Charité – Universitätsmedizin Berlin, Germany

Care for ME/CFS

Chairs
Uta Behrends
Uta Behrends, Technical University of Munich (TUM) Hospital and Munich Schwabing Clinic, Germany
Kristian Sommerfelt
Kristian Sommerfelt, University of Bergen, Norway
11:00
15 min
11:15
15 min

The Akureyri Clinic

Fridbjörn Sigurdsson
Fridbjörn Sigurdsson, Landspitali - University Hospital, Reykjavik, Iceland
11:30
15 min
11:45
15 min

Clinical care for ME/CFS

Michael Stingl
Michael Stingl, Dr. Michael Stingl Private Practice, Austria
12:00
15 min

Long/Post-COVID Off-Label-Use of Drugs in Germany

Bernhard Wörmann
Bernhard Wörmann, Charité – Universitätsmedizin Berlin, Germany
12:15
15 min

Posters

Chairs
Martina Seifert
Martina Seifert, Charité – Universitätsmedizin Berlin, Germany
Wolfram Döhner
Wolfram Döhner, Charité – Universitätsmedizin Berlin, Germany
12:50
5 min
13:00
75 min

Posters & Exchange & Lunch

Understanding I: Cardiovascular dysregulation and mitochondrial pathology

Chairs
Klaus Wirth
Klaus Wirth, Mitodicure GmbH, Germany
David Systrom
David Systrom, Brigham and Women's Hospital and Harvard Medical School, Boston, USA
14:15
15 min

Circulatory dysfunction in ME/CFS

David Systrom
David Systrom, Brigham and Women's Hospital and Harvard Medical School, Boston, USA
14:30
15 min

Skeletal muscle alterations in Long COVID and ME/CFS

Rob Wust
Rob Wust, Vrije Universiteit (VU) Amsterdam, Netherlands
14:45
15 min

Functional and Morphological Changes in Mitochondria in Muscle

Jürgen Steinacker
Jürgen Steinacker, Institute of Rehabilitation Medicine Research at Ulm University, Germany
15:00
15 min

Mechanisms of Post-Exertional Malaise (PEM)

Christian Puta
Christian Puta, Friedrich Schiller University Jena, Germany
15:30
45 min

Posters & Coffee

Understanding II: Immune dysregulation and autoimmunity

Chairs
Gabriela Riemekasten
Gabriela Riemekasten, University Hospital Schleswig-Holstein (UKSH), Lübeck, Germany
Yehuda Shoenfeld
Yehuda Shoenfeld, Tel Aviv University, Israel
16:15
20 min

Autoimmunity as a cause of Long COVID and ME/CFS

Jeroen den Dunnen
Jeroen den Dunnen, Amsterdam University Medical Center (UMC), Netherlands
16:35
20 min

GPCR autoantibodies in ME/CFS and brain alterations

Takashi Yamamura
Takashi Yamamura, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
16:55
15 min

Autoantibodies mimicking EBV sequences in ME/CFS and PCS

Franziska Sotzny
Franziska Sotzny, Charité – Universitätsmedizin Berlin, Germany
17:10
15 min

Autoantibodies to neuronal antigens in ME/CFS and PCS

Christiana Franke
Christiana Franke, Charité – Universitätsmedizin Berlin, Germany
17:25
15 min

T and B cell responses in ME/CFS

Birgit Sawitzki
Birgit Sawitzki, Charité – Universitätsmedizin Berlin, Germany
18:00

Get Together & Dinner

13.05.2025 - Tuesday (Day 2)

All times are in Central European Summer Time (CEST).

Treatment I: Clinical trials targeting autoantibodies

Chairs
Nina Babel
Nina Babel, Charité – Universitätsmedizin Berlin, Germany
Yehuda Shoenfeld
Yehuda Shoenfeld, Tel Aviv University, Israel
9:40
10 min
9:50
10 min

Rituximab trial in Japan

Wakiro Sato
Wakiro Sato, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
10:00
10 min

Efficacy of repeated immunoadsorption in post-COVID ME/CFS

Elisa Stein
Elisa Stein, Charité – Universitätsmedizin Berlin, Germany
10:10
10 min

Immunoadsorption in severely ill ME/CFS patients

Georg Schlieper
Georg Schlieper, Dialysis Hannover - Center for Kidney, Hypertension and Metabolic Diseases, Germany
10:20
30 min

Coffee

Treatment II: Clinical trials

Chairs
Christiana Franke
Christiana Franke, Charité – Universitätsmedizin Berlin, Germany
Jürgen Steinacker
Jürgen Steinacker, Institute of Rehabilitation Medicine Research at Ulm University, Germany
11:00
15 min

Overview of IgG therapy in ME/CFS and PCS

Nina Babel
Nina Babel, Charité – Universitätsmedizin Berlin, Germany
11:15
15 min
11:45
20 min

Targeting viral persistence in Post-COVID Syndromes

Michael Peluso
Michael Peluso, University of California San Francisco (UCSF), USA
12:05
10 min

Low-dose Naltrexone & Mestinon RCT in ME/CFS and Long COVID

David Systrom
David Systrom, Brigham and Women's Hospital and Harvard Medical School, Boston, USA
12:15
10 min
12:45

Poster Award & Lunch & Adjourn

Sponsors

Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo